Jiaping Li
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
Papers in
- Hepatology 54
- Hepatocellular Carcinoma Treatment and Prognosis 52
-
- Gallbladder and Bile Duct Disorders 6
- Ferroptosis and cancer prognosis 6
- Co-authors
- Wenzhe Fan (63 shared papers)Pierre Layrolle (2 shared papers)Klaas de Groot (2 shared papers)Jizhou Tan (11 shared papers)Yingqiang Zhang (24 shared papers)Baogang Peng (5 shared papers)Jianyong Yang (18 shared papers)Pamela Habibović (7 shared papers)
- Journals
- Oncotarget (5 papers)Frontiers in Oncology (5 papers)Journal of Vascular and Interventional Radiology (5 papers)Journal of Clinical Oncology (5 papers)International Journal of Hyperthermia (4 papers)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Jiaping Li
193 papers receiving 4.6k citations
Jiaping Li's Hit Papers
Peers
Comparison fields: 5 of 170
- Hepatology 1.2k
- Cancer Research 317
- Oncology 533
- Oral Surgery 133
- Biomaterials 264
Countries citing papers authored by Jiaping Li
This map shows the geographic impact of Jiaping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping Li more than expected).
Fields of papers citing papers by Jiaping Li
This network shows the impact of papers produced by Jiaping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping Li. The network helps show where Jiaping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) Hit paper breakdown → | 2022 | 286 |
| 2 | 2004 | 195 | |
| 3 | 2003 | 188 | |
| 4 | 2020 | 172 | |
| 5 | 2020 | 150 | |
| 6 | TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma Hit paper breakdown → | 2023 | 139 |
| 7 | 2009 | 136 | |
| 8 | 2012 | 110 | |
| 9 | 2019 | 107 | |
| 10 | 2020 | 96 | |
| 11 | 2012 | 83 | |
| 12 | 2009 | 82 | |
| 13 | 2015 | 80 | |
| 14 | 2019 | 76 | |
| 15 | 2021 | 71 | |
| 16 | 2016 | 67 | |
| 17 | 2011 | 67 | |
| 18 | 2023 | 66 | |
| 19 | 2015 | 61 | |
| 20 | 2018 | 61 |
About Jiaping Li
Jiaping Li is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Biomedical Engineering, Molecular Biology and Oncology, having authored 200 papers that have together received 4.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (52 papers), Bone Tissue Engineering Materials (10 papers), Cancer Mechanisms and Therapy (10 papers), Geotechnical Engineering and Underground Structures (7 papers), Gallbladder and Bile Duct Disorders (6 papers), Ferroptosis and cancer prognosis (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (317 citations), Oncology (533 citations), Oral Surgery (133 citations) and Biomaterials (264 citations). Jiaping Li has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Wenzhe Fan, Pierre Layrolle, Klaas de Groot, Jizhou Tan, Yingqiang Zhang, Baogang Peng, Jianyong Yang, Pamela Habibović, Ting Liu and Yu Wang. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Journal of Vascular and Interventional Radiology, Journal of Clinical Oncology and International Journal of Hyperthermia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.